Long COVID: Highlights of the Study
Anti-inflammatory signature: Patients with Long COVID Syndrome (LCS) show a consistent pattern of anti-inflammatory molecules in blood plasma.
Diagnostic potential: This proteomics and metabolomics pattern could be used for diagnostics and monitoring of Long COVID.
Possible mechanisms: Alternatively polarized macrophages may play a role in the underlying pathomechanisms of LCS.
Key molecules identified: High levels of anti-inflammatory oxylipins, including omega-3 fatty acids, were detected in LCS using eicosadomics.
New perspective: These findings suggest a new vision for understanding immune responses in COVID-19 recovery.
Reference / Contact:
Johannes J. Kovarik, Andrea Bileck, Gerhard Hagn, Mariann Gyöngyösi, Klaus G. Schmetterer, Christopher Gerner
mariann.gyongyosi@meduniwien.ac.at | klaus.schmetterer@meduniwien.ac.at | christopher.gerner@univie.ac.at
Access the full publication: Read the study
Kovarik J.J. et al. A multi-omics based anti-inflammatory immune signature in Long COVID syndrome, iScience, 2023.
